Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.116 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.116 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.116 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.116 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.116 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.116 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.38 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.38 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.38 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.38 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.38 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.38 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.38 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.38 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.413EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.413EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.413ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.413ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.413EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.413EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.413ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.413ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.5.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.5.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.5.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FY.5.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FY.5.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FY.5.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.5.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.5.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JD.1.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JD.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.2.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JD.1.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JD.1.2.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JD.1.2.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JD.1.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JD.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.268EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.268EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.268ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.268ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.268EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.268EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.268ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.268ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.409EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.409EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.409ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.409ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used